Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP549944.RAfYFzm0Cuv1U9gzlJznN3f9h8h8ltsGjsYT-WeUfw_2E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP549944.RAfYFzm0Cuv1U9gzlJznN3f9h8h8ltsGjsYT-WeUfw_2E130_assertion type Assertion NP549944.RAfYFzm0Cuv1U9gzlJznN3f9h8h8ltsGjsYT-WeUfw_2E130_head.
- NP549944.RAfYFzm0Cuv1U9gzlJznN3f9h8h8ltsGjsYT-WeUfw_2E130_assertion description "[MRP (multidrug resistance protein) expression was detected in 20.5% of 88 myeloma samples, in 26% at the mRNA level analyzed by quantitative reverse transriptase-polymerase chain reaction, and in only 3 of 79 samples by immunohistochemistry.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP549944.RAfYFzm0Cuv1U9gzlJznN3f9h8h8ltsGjsYT-WeUfw_2E130_provenance.
- NP549944.RAfYFzm0Cuv1U9gzlJznN3f9h8h8ltsGjsYT-WeUfw_2E130_assertion evidence source_evidence_literature NP549944.RAfYFzm0Cuv1U9gzlJznN3f9h8h8ltsGjsYT-WeUfw_2E130_provenance.
- NP549944.RAfYFzm0Cuv1U9gzlJznN3f9h8h8ltsGjsYT-WeUfw_2E130_assertion SIO_000772 12180485 NP549944.RAfYFzm0Cuv1U9gzlJznN3f9h8h8ltsGjsYT-WeUfw_2E130_provenance.
- NP549944.RAfYFzm0Cuv1U9gzlJznN3f9h8h8ltsGjsYT-WeUfw_2E130_assertion wasDerivedFrom befree-20140225 NP549944.RAfYFzm0Cuv1U9gzlJznN3f9h8h8ltsGjsYT-WeUfw_2E130_provenance.
- NP549944.RAfYFzm0Cuv1U9gzlJznN3f9h8h8ltsGjsYT-WeUfw_2E130_assertion wasGeneratedBy ECO_0000203 NP549944.RAfYFzm0Cuv1U9gzlJznN3f9h8h8ltsGjsYT-WeUfw_2E130_provenance.